Medpace Holdings, Inc.

This proposal requests the Board amend Medpace’s governing documents to permit shareholders holding a combined 10% of outstanding common stock (or the lowest percentage permitted by state law) to call a special shareholder meeting, with provision for an online meeting and no minimum holding period. The proposal seeks to remove "poison pill" style restrictions and other barriers that would prevent shareholders from convening such a meeting. The supporting statement argues this right would help hold the Board and management accountable and notes recent company-specific concerns cited by the proponent (weak book-to-bill metrics, an external investigation referenced, revenue concentration among smaller biopharma clients, and reported insider selling). If implemented, the change would give a defined minority of shareholders a mechanism to request immediate stockholder action between annual meetings.